Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS??? EQUITY (Tables)

v3.24.1
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of warrants activity
                       
    Common Stock Warrants  
    Shares     Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Life in years
    Intrinsic Value  
                         
Outstanding at January 1, 2023     67,060     $ 524.97                  
Granted (1)     6,399,061     $ 4.71                  
Canceled         $                  
Exchanged     (40,260 )   $ 641.25                  
Expired         $                  
Exercised     (813,774 )   $ 19.38                  
Outstanding at December 31, 2023     5,612,087     $ 7.04       4.87     $ 0  
Exercisable at December 31, 2023     5,612,087     $ 7.04       4.87     $ 0  

 

(1) The number of warrants granted and the weighted average exercise price is based on the adjustment to certain warrants as of February 2, 2024, the date of the Company’s 1 for 45 reverse stock split. As discussed above, further adjustments occurred based on the change in the change in the VWAP of the Company’s common stock from February 2, 2024 and due to the exchange of the May 2023 Notes for Series A convertible preferred stock on March 4, 2024.